Table 5 Univariate logistic regression regarding progression free survival (PFS).

From: Influence of capping chemotherapy prescriptions on efficacy and tolerability in medium and high-risk early-stage breast cancer

Variable

Univariate

Multivariable

Capping groups

OR (95% CI)

p

 

Adjusted OR (95% CI)

p

Capping group

Reference group [90–100]

 

Reference group [90–100]

  

[0–10[

2.61 (0.43–15.67)

0.294

[0–10[

2.59 (0.43–15.73)

0.302

[10–50[

5.02 (1.12–22.53)

0.035

[10–50[

3.79 (0.81–17.74)

0.09

[50–90[

3.33 (0.75–14.76)

0.113

[50–90[

3.05 (0.68–13.68)

0.145

Chemotherapy

Neoadjuvant vs. adjuvant

2.93 (1.17–7.37)

0.118

 

2.19 (0.82–5.87)

0.139

  1. HR Hazard ratio.
Back to article page